National Academy of Medicine

It’s Time to Harmonize Clinical Trial Site Standards

Climbing costs and lengthy time frames of clinical trials are significant bottlenecks in medical product development. Despite the fact that scientifi
Read More

Alternatives to Antibiotics: Why and How

The antibiotic resistance problem is caused by the evolution and transfer of genes that confer resistance to medically important antibiotics into human pathogens
Read More

Manufacturing Cell Therapies: The Paradigm Shift in Health Care of This Century

Recent advances in cell biology and genetic engineering have changed the way we think about medicine. Indeed, we are witne
Read More

An American Crisis: The Lack of Black Men in Medicine

This paper originally appeared in the Journal of Racial and Ethnic Health Disparities (2017) 4:317-321. Reprinted by permission.   The current
Read More

Real-World Evidence to Guide the Approval and Use of New Treatments

Research regarding new treatments (drugs, biological products, and high-risk devices) often begins with a broad assessment of disease
Read More